Director, Biostatistics at Kardigan

South San Francisco, California, United States -

Full Time

Start Date

Immediate

Expiry Date

12 Jan, 26

Salary

280000.0

Posted On

14 Oct, 25

Experience

10 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Biostatistics, Clinical Trials, Statistical Analysis, Data Monitoring, CRO Management, Statistical Software, Machine Learning, Data Visualization, Regulatory Submissions, Statistical Methodology, Team Collaboration, Mentoring, Process Improvement, Communication, Presentation Skills, Cardiovascular Drug Development

Industry

Description

About Us Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world. It is Kardigan’s mission to develop multiple targeted treatments in parallel that bring people with cardiovascular diseases to the cures they deserve. Led by Tassos Giannakakos, Jay Edelberg, M.D. and Bob McDowell, Ph.D., Kardigan’s co-founders have reunited after leading MyoKardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020. We have a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and an industry-leading team that is driven to improve the lives of patients. At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals. Driven by patients and their families, we are deeply committed to improving the lives of patients and prioritizing their needs above all else. We believe in being authentic—leading with truth to bring out the best in others by creating an environment where every person knows they will be fully accepted. With an eagerness to learn, we encourage the highest levels of curiosity and are open to changing our minds. We are committed to winning as a team with urgency, excellence, and intention, and support each other no matter what role we play or where we sit. Lastly, we strive to enable the impossible because patients are counting on us. We are not afraid to take risks to unlock innovation and advance scientific discoveries. These values are the foundation of our work, empowering us to make a real difference, every day. Position Title: Director, Biostatistics Department: Development - Data Science Reports To: Senior Director, Biostatistics Location: Princeton, NJ or South San Francisco, CA – On-site 4 days per week (Mon to Thurs) Job Overview We are seeking a highly skilled and motivated Biostatistician to lead our biometrics function in one of the late-phase programs for cardiovascular drug development. As the Biostatistician, you will be the compound lead, representing biometrics at the project team level. You will be responsible for discussing and shaping the clinical development plan, study design, endpoint selection, statistical analysis plan, and regulatory submission and publication strategy to support pursuant of precision medicine. This role involves overseeing CROs and collaborating with cross-functional teams to deliver high-quality analysis outputs and interpret results. This position reports to the Senior Director, Biostatistics based in South San Francisco, CA. The role has one opening and may be located in either our Princeton, NJ office or our South San Francisco, CA office. Essential Duties and Responsibilities Collaborate with clinical, regulatory, medical affairs, and other teams to ensure cohesive and integrated project strategies. Contribute to clinical protocol development and study reports, including authoring of the Statistics section and reviewing of other sections by applying statistical principles. Author or review statistical analysis plans for clinical trials and for integrated summaries of safety/effectiveness (ISS/ISE), and author or oversee the development of shells for tables, figures and listings. Review case report form (CRF) designs to ensure data collection meet the requirements of statistical analyses. Provide statistical input to data monitoring committee (DMC) charters. Oversee the CROs or internal teams to deliver high-quality and timely analysis outputs and interpret the results. Manage statistical activities in support of NDA/MAA or other regulatory submissions. Address statistical questions/comments from FDA and other regulatory agencies. Support and contribute to the preparation of publications, including manuscripts, posters and oral presentations. Contribute or lead standardization and process improvement efforts for Biostatistics and contributes to cross-functional process improvement efforts. Provide guidance and oversight to ensure compliance with regulatory standards and best practices. Mentor junior statisticians. Qualifications and Preferred Skills PhD in Statistics, Biostatistics, or a related scientific field with 8+ years of experience, or MS with 10+ years of experience in clinical trials, drug development, the pharmaceutical industry, or healthcare. Expertise in applying knowledge of general and cutting edge statistical / clinical trials methodology to solve complex statistical problems in the clinical development area and ensure alignment with regulatory agencies and industry standards. Knowledgeable of machine learning approaches for classification and predictive modeling. Excellent communication and presentation skills, with the ability to convey complex statistical concepts to non-statisticians. Strong knowledge of statistical software (SAS, R or Python) and proficiency in implementation of advanced analytical methods especially for data visualization. Experience in managing CROs and collaborating with cross-functional teams. Experience with NDAs, and MAA’s is highly desired. Experience with cardiovascular drug development and digital health data or real-world data is preferred. Demonstrated ability to work independently and as part of a team in a fast-paced, dynamic environment. Exact Compensation may vary based on skills, experience and location. Pay range $204,000—$280,000 USD

Responsibilities

Lead the biometrics function for late-phase cardiovascular drug development programs. Collaborate with cross-functional teams to shape clinical development plans and oversee statistical analysis outputs.